Associate Director, commercial insight and forecast at Bristol-Myers Squibb

Shanghai, China

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, BiotechnologyIndustries

Requirements

Demonstrated expertise in business forecasting, market analytics, and strategic planning within the industry (more than 7 years industry experience)
Experience in cross-functional collaboration and stakeholder management
Proficiency in integrating diverse data sources to generate actionable business insights
Strong leadership and team development skills

Responsibilities

Lead forecasting processes, providing timely assumption changes based on evolving market conditions and strategic priorities
Deliver integrated business insights by synthesizing market research, data analysis, and competitive intelligence for launch readiness
Collaborate with marketing, finance, demand forecasting, market access, and sales effectiveness teams to conduct ad-hoc analytics as required by business needs
Conduct company-level analyses and engage with China leadership and global BI&A colleagues to support long-term forecasting and strategic planning, including China 2030 strategy analytics
Manage and develop a team of senior managers specializing in IO forecasting and insight analytics
Foster cross-functional collaboration and knowledge sharing to enhance analytical capabilities and business impact
Lead forecasting and business insights for CV and Pipeline products
Collaborate with cross-functional teams to update business assumptions in response to market dynamics and company strategy
Integrate findings from primary research, secondary data, and competitor intelligence to shape the launch strategy

Skills

Forecasting

Business Insights

Market Research

Data Analysis

Competitive Intelligence

Strategic Planning

Analytics

Team Management

Primary Research

Secondary Data

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free